Preferred Label : Nerlynx;
Origin ID : M000675477;
Manual NTBT mappings (CISMeF)
- Related record
https://www.has-sante.fr/jcms/p_3443498/fr/nerlynx-neratinib-cancer-du-sein
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
Adjuvant Therapy
Early-Stage HER2 Positive Breast Cancer
adult
administration, oral
Product containing precisely neratinib (as neratinib maleate) 40 milligram/1 each
conventional release oral tablet (clinical drug)
neratinib
HER2 Inhibitor
evaluation of the transparency committee
breast neoplasms
Nerlynx
neratinib
---
